Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Cerny

Showing results (51-60 of 93) with videos related to

Pageof 10
Sort By:
Open Forum Infectious Diseases|August 29, 2020
All-Cause Mortality and Causes of Death in the Swiss Hepatitis C Cohort Study (SCCS)Maroussia Roelens, Barbara Bertisch, Darius Moradpour, et al.
Scientific Reports|June 6, 2023
A computationally efficient algorithm for wearable sleep staging in clinical populationsPedro Fonseca, Marco Ross, Andreas Cerny, et al.
Swiss Medical Weekly|August 8, 2012
Characteristics of patients with chronic hepatitis C who develop hepatocellular carcinomaLorenz Kuske, Armand Mensen, Beat Müllhaupt, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 13, 2006
Randomized placebo-controlled trial of ursodeoxycholic acid with vitamin e in nonalcoholic steatohepatitisJean-François Dufour, Carl M Oneta, Jean-Jacques Gonvers, et al.
Journal of Virology|January 11, 2008
Increased cytotoxic T-lymphocyte epitope variant cross-recognition and functional avidity are associated with hepatitis C virus clearanceDaniel Yerly, David Heckerman, Todd M Allen, et al.
Journal of Hepatology|January 18, 2011
Viral genotype-specific role of PNPLA3, PPARG, MTTP, and IL28B in hepatitis C virus-associated steatosisTao Cai, Jean-François Dufour, Beat Muellhaupt, et al.
Swiss Medical Weekly|December 18, 2019
Nonalcoholic fatty liver disease burden - Switzerland 2018-2030Nicolas Goossens, Stefano Bellentani, Andreas Cerny, et al.
BMC Gastroenterology|July 6, 2010
Hyperimmune anti-HBs plasma as alternative to commercial immunoglobulins for prevention of HBV recurrence after liver transplantationFlorian Bihl, Stefan Russmann, Vanina Gurtner, et al.
Journal of Hepatology|August 12, 2009
Genotype 3 is associated with accelerated fibrosis progression in chronic hepatitis CPierre-Yves Bochud, Tao Cai, Kathrin Overbeck, et al.
Journal of Viral Hepatitis|October 21, 2006
HCV-related advanced fibrosis/cirrhosis: randomized controlled trial of pegylated interferon alpha-2a and ribavirinBeat Helbling, Wolfram Jochum, Ivan Stamenic, et al.
Pageof 10

Showing results (51-60 of 93) with videos related to

Sort By:
Pageof 10
Open Forum Infectious Diseases|August 29, 2020
All-Cause Mortality and Causes of Death in the Swiss Hepatitis C Cohort Study (SCCS)Maroussia Roelens, Barbara Bertisch, Darius Moradpour, et al.
Scientific Reports|June 6, 2023
A computationally efficient algorithm for wearable sleep staging in clinical populationsPedro Fonseca, Marco Ross, Andreas Cerny, et al.
Swiss Medical Weekly|August 8, 2012
Characteristics of patients with chronic hepatitis C who develop hepatocellular carcinomaLorenz Kuske, Armand Mensen, Beat Müllhaupt, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 13, 2006
Randomized placebo-controlled trial of ursodeoxycholic acid with vitamin e in nonalcoholic steatohepatitisJean-François Dufour, Carl M Oneta, Jean-Jacques Gonvers, et al.
Journal of Virology|January 11, 2008
Increased cytotoxic T-lymphocyte epitope variant cross-recognition and functional avidity are associated with hepatitis C virus clearanceDaniel Yerly, David Heckerman, Todd M Allen, et al.
Journal of Hepatology|January 18, 2011
Viral genotype-specific role of PNPLA3, PPARG, MTTP, and IL28B in hepatitis C virus-associated steatosisTao Cai, Jean-François Dufour, Beat Muellhaupt, et al.
Swiss Medical Weekly|December 18, 2019
Nonalcoholic fatty liver disease burden - Switzerland 2018-2030Nicolas Goossens, Stefano Bellentani, Andreas Cerny, et al.
BMC Gastroenterology|July 6, 2010
Hyperimmune anti-HBs plasma as alternative to commercial immunoglobulins for prevention of HBV recurrence after liver transplantationFlorian Bihl, Stefan Russmann, Vanina Gurtner, et al.
Journal of Hepatology|August 12, 2009
Genotype 3 is associated with accelerated fibrosis progression in chronic hepatitis CPierre-Yves Bochud, Tao Cai, Kathrin Overbeck, et al.
Journal of Viral Hepatitis|October 21, 2006
HCV-related advanced fibrosis/cirrhosis: randomized controlled trial of pegylated interferon alpha-2a and ribavirinBeat Helbling, Wolfram Jochum, Ivan Stamenic, et al.
Pageof 10